Faro AI: Series B

The business

Faro AI builds data infrastructure for clinical drug development and AI agents to automate work across clinical trials. Its platform is intended to help pharmaceutical teams organize trial information and streamline development processes, with Merck Global Health Innovation Fund among the co-leads of the Series B. The company raised $37.3 million to expand its clinical-development agent capabilities.

Funding history

Aug 30, 2026Series B · This round$37.3M

Sources

Faro AI Raises $37.3M for AI Agents in Clinical Trialsaibusinessweekly.net · Aug 30, 2026

Similar rounds

All Healthtech rounds →

Cori Clinical

Cori Clinical combines prior study knowledge, external trial registries and FDA, MHRA and EMA guidance in an AI workspace for clinical teams. Teams turn an initial brief into a protocol, regulatory submission package and operational plan, with design choices linked to budgets and timelines.

€3.8MSeed · Oct 7, 2026

General Medicine

An online healthcare store where people compare care options and upfront prices, book visits and order medications or lab tests.

$120MSeries B · Oct 6, 2026

Vitalize

Vitalize helps hospital teams coordinate staffing and capacity as patient demand shifts.

$31MSeries A · Oct 6, 2026

Zenflow

A minimally invasive implant system designed to relieve urinary symptoms caused by an enlarged prostate.

$52MSeries D · Oct 5, 2026

The business

Funding history

Sources

Similar rounds

Related